A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

VCU Massey Comprehensive Cancer Center, Richmond

University of Florida Health Science Center - Gainesville, Gainesville

Ohio State University Comprehensive Cancer Center, Columbus

Wayne State University/Karmanos Cancer Institute, Detroit

Weisberg Cancer Treatment Center, Farmington Hills

Mayo Clinic in Rochester, Rochester

Washington University School of Medicine, St Louis

UCHealth University of Colorado Hospital, Aurora

Mayo Clinic Hospital in Arizona, Phoenix

Stanford Cancer Institute Palo Alto, Palo Alto

Mayo Clinic in Florida, Jacksonville

Massachusetts General Hospital Cancer Center, Boston

Dana-Farber Cancer Institute, Boston